159619 Resolving conflicts between FERPA and public health data collection

Wednesday, November 7, 2007: 9:00 AM

Martha Dewey Bergren, DNS RN CSN FNASN , National Association of School Nurses, Silver Spring, MD
The Family Education Rights Privacy Act (FERPA) was enacted in 1974 to protect the education privacy rights of students and their families. School health records are covered by FERPA., not the Health Insurance Portability and Accountability Act (HIPAA). Information covered by HIPAA can be shared for public health purposes without a written authorization to release information. However, US Department of Education FERPA memorandums issued in response to state and CDC inquiries state clearly that identifiable student health information in education records may not be shared for public health purposes. This includes personally identifiable state immunization reporting data, mandatory communicable disease reporting and surveillance and registry information regarding congenital and chronic diseases used to advise health policy. If student health records were covered by HIPAA, the exchange of information without authorization public health exemption would apply to this exchange of data, a tradition public health role of schools. This is especially pertinent in the beginning stages of a pandemic flu and other public health crises that do not meet the FERPA definition of an emergency. This session will share state and federal updates on this dilemma and provide strategies for obtaining information needed for public health purposes.

Learning Objectives:
Discuss updates in conflicts between FERPA and state and national public health data collection Assess strategies for resolution of conflict between need for public health data collection and student privacy protections

Keywords: Privacy, Data Collection

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.